These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1166120)
21. Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses. Bartley K; Deane D; Percival A; Dry IR; Grant DM; Inglis NF; Mclean K; Manson ED; Imrie LH; Haig DM; Lankester F; Russell GC Vet Microbiol; 2014 Sep; 173(1-2):17-26. PubMed ID: 25091530 [TBL] [Abstract][Full Text] [Related]
22. Virologic studies on cattle with naturally occurring and experimentally induced malignant catarrhal fever. Storz J; Okuna N; McChesney AE; Pierson RE Am J Vet Res; 1976 Aug; 37(8):875-8. PubMed ID: 949113 [TBL] [Abstract][Full Text] [Related]
23. RhinoVax is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant. Mayo SL; Tufvesson M; Carlsson HE; Royo F; Gizurarson S; Hau J In Vivo; 2005; 19(2):375-82. PubMed ID: 15796200 [TBL] [Abstract][Full Text] [Related]
24. Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever. Russell GC; Benavides J; Grant D; Todd H; Deane D; Percival A; Thomson J; Connelly M; Haig DM Vet Res; 2012 Jun; 43(1):51. PubMed ID: 22686373 [TBL] [Abstract][Full Text] [Related]
25. An evaluation of distress following intraperitoneal immunization with Freund's adjuvant in mice. Toth LA; Dunlap AW; Olson GA; Hessler JR Lab Anim Sci; 1989 Mar; 39(2):122-6. PubMed ID: 2709800 [TBL] [Abstract][Full Text] [Related]
27. The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle. Parameswaran N; Russell GC; Bartley K; Grant DM; Deane D; Todd H; Dagleish MP; Haig DM Vet Res; 2014 May; 45(1):59. PubMed ID: 24886334 [TBL] [Abstract][Full Text] [Related]
28. Etiology of malignant catarrhal fever outbreak in Minnesota. Hamdy FM; Dardiri AH; Mebus C; Pierson RE; Johnson D Proc Annu Meet U S Anim Health Assoc; 1978; (82):248-67. PubMed ID: 287095 [No Abstract] [Full Text] [Related]
29. A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated malignant catarrhal fever in cattle. Cook E; Russell G; Grant D; Mutisya C; Omoto L; Dobson E; Lankester F; Nene V Vaccine; 2019 Sep; 37(40):5946-5953. PubMed ID: 31473000 [TBL] [Abstract][Full Text] [Related]
30. [The etiology of "malignant catarrhal fever" originating in sheep: serological findings in cattle and sheep with ruminant gamma herpesviruses]. Metzler AE; Burri HR Tierarztl Prax; 1991 Apr; 19(2):135-40. PubMed ID: 2068708 [TBL] [Abstract][Full Text] [Related]
31. Biphenyl-exposed rabbits. Koller LD; Thigpen JE Am J Vet Res; 1973 Dec; 34(12):1605-6. PubMed ID: 4202752 [No Abstract] [Full Text] [Related]
32. Enzyme-linked immunosorbent assay for the detection of antibodies to the alcelaphine herpesvirus of malignant catarrhal fever in exotic ruminants. Wan SK; Castro AE; Heuschele WP; Ramsay EC Am J Vet Res; 1988 Feb; 49(2):164-8. PubMed ID: 3348526 [TBL] [Abstract][Full Text] [Related]
33. Studies on the development of a vaccine against bovine ephemeral fever. Theodoridis A; Boshoff SE; Botha MJ Onderstepoort J Vet Res; 1973 Sep; 40(3):77-82. PubMed ID: 4788558 [No Abstract] [Full Text] [Related]
34. Studies concerning etiology of sheep-associated malignant catarrhal fever in Europe. Muluneh A; Liebermann H Dtsch Tierarztl Wochenschr; 1992 Sep; 99(9):384-6. PubMed ID: 1396168 [TBL] [Abstract][Full Text] [Related]
36. Antibody response of calves to immunoaffinity-purified bovine respiratory syncytial virus VP70 after vaccination and challenge exposure. Nelson LD; Kelling CL; Anderson GA Am J Vet Res; 1992 Aug; 53(8):1315-21. PubMed ID: 1510306 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of the herpesvirus of malignant catarrhal fever isolated from captive wildebeest calves. Castro AE; Ramsay EC; Dotson JF; Schramke ML; Kocan AA; Whitenack DL Am J Vet Res; 1984 Mar; 45(3):409-15. PubMed ID: 6324620 [TBL] [Abstract][Full Text] [Related]
38. A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle. Lankester F; Russell GC; Lugelo A; Ndabigaye A; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Percival A; Deane D; Haig DM; Cleaveland S Vaccine; 2016 Feb; 34(6):831-8. PubMed ID: 26706270 [TBL] [Abstract][Full Text] [Related]
39. Antibody response in cattle and rabbits to early antigens of malignant catarrhal fever virus in cultured cells. Rossiter PB; Mushi EZ; Plowright W Res Vet Sci; 1978 Sep; 25(2):207-10. PubMed ID: 364579 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]